New Funding Partnership with Pharmacy Research UK

The Research Awards will support projects in translational and health service research related to oncology and haematology pharmacy with a focus on patient benefit and provide a platform for novice researchers to engage in research. Through these awards PRUK and BOPA aim to build the capacity for research within oncology and haematology pharmacy, provide evidence to inform healthcare policy and to highlight the vital role of pharmacists and pharmacy technicians in the wider healthcare community.

Dr Rachel Joynes, Head of Research and Evaluation at Pharmacy Research UK said ‘We are delighted to be announcing this new partnership with BOPA which we hope will not only allow both pharmacists and pharmacy technicians to undertake research but also presents an opportunity for those new to research to lead their first project’.

Carl Booth, Chair of the BOPA Audit and Research Sub-Committee notes ‘BOPA is incredibly excited to be funding our first research projects to build the base of evidence in oncology and haematology pharmacy. We hope this funding will allow our members to explore previously unanswered questions and will support the development of new skills and future opportunities’.

Successful applicants will be invited to present their work at the BOPA annual symposium in 2017.

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article